INCREASED ANTI-XA BIOAVAILABILITY FOR A LOW-MOLECULAR WEIGHT HEPARIN (PK-10169) COMPARED WITH UNFRACTIONATED HEPARIN

被引:24
|
作者
BARA, L
BILLAUD, E
KHER, A
SAMAMA, M
机构
[1] HOTEL DIEU,CENT HEMATOL LAB,F-75181 PARIS 04,FRANCE
[2] HOP BROUSSAIS,DEPT PHARMACOL CLIN,F-75674 PARIS 14,FRANCE
来源
SEMINARS IN THROMBOSIS AND HEMOSTASIS | 1985年 / 11卷 / 03期
关键词
D O I
10.1055/s-2007-1004384
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:316 / 317
页数:2
相关论文
共 50 条
  • [1] COMPARATIVE PHARMACOKINETICS OF A LOW-MOLECULAR WEIGHT HEPARIN (PK-10169) AND UNFRACTIONATED HEPARIN (UH) AFTER INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATION
    BARA, L
    BILLAUD, E
    GRAMOND, G
    SAMAMA, M
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 309 - 309
  • [2] A NEW LOW-MOLECULAR WEIGHT HEPARIN FRAGMENT (PK-10169) - INVITRO AND INVIVO STUDIES
    VINAZZER, H
    WOLER, M
    THROMBOSIS RESEARCH, 1985, 40 (02) : 135 - 146
  • [3] A LOW-MOLECULAR WEIGHT HEPARIN COMPARED WITH UNFRACTIONATED HEPARIN
    THOMAS, DP
    MERTON, RE
    THROMBOSIS RESEARCH, 1982, 28 (03) : 343 - 350
  • [4] ANTI-XA POTENTIATING EFFECT OF LOW-MOLECULAR WEIGHT HEPARIN
    JUNKER, W
    HARENBERG, J
    FUSSI, F
    MATTES, K
    ZIMMERMANN, R
    WEBER, E
    THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 235 - 235
  • [5] COMPARATIVE EFFECTS OF HEPARIN AND PK-10169, A LOW-MOLECULAR WEIGHT FRACTION, IN A CANINE MODEL OF ARTERIAL THROMBOSIS
    MESTRE, M
    CLAIREFOND, P
    MARDIGUIAN, J
    TRILLOU, M
    LEFUR, G
    UZAN, A
    THROMBOSIS RESEARCH, 1985, 38 (04) : 389 - 399
  • [6] INVITRO COAGULANT AND AMIDOLYTIC METHODS FOR EVALUATING THE ACTIVITY OF HEPARIN AND A LOW-MOLECULAR WEIGHT DERIVATIVE (PK-10169)
    WALENGA, JM
    FAREED, J
    HOPPENSTEADT, DA
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1985, 11 (01): : 17 - 25
  • [7] COMPARATIVE EFFECTS OF HEPARIN AND PK-10169, A LOW-MOLECULAR WEIGHT FRACTION, IN A CANINE MODEL OF ARTERIAL THROMBOSIS
    MESTRE, M
    CLAIREFOND, P
    MARDIGUIAN, J
    TRILLOU, M
    LEFUR, G
    UZAN, A
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1985, 11 (02): : 245 - 245
  • [8] Very low doses of unfractionated heparin potentiate the anti-Xa activity of low molecular weight heparin (enoxaparin)
    PerezRequejo, JL
    LucenaSolano, O
    PerezGarcia, M
    Santarelli, MT
    THROMBOSIS RESEARCH, 1997, 85 (03) : 259 - 265
  • [9] Very low doses of unfractionated heparin potentiate the anti-Xa activity of low molecular weight heparin (Enoxaparin)
    PerezRequejo, JL
    LucenaSolano, O
    PerezGarcia, M
    Santarelli, MT
    THROMBOSIS AND HAEMOSTASIS, 1997, : P1172 - P1172
  • [10] LOWER ENHANCEMENT INVITRO OF AT III-MEDIATED ANTIPLASMIN ACTIVITY BY LOW-MOLECULAR WEIGHT HEPARIN, PK-10169 (MW-5,000) THAN BY UNFRACTIONATED HEPARIN
    BARA, L
    KHER, A
    SAMAMA, M
    HAEMOSTASIS, 1984, 14 (01) : 119 - 119